In seeking a data-driven approach to efficient drug development, MMS aims to enhance its...
Author - David Miller
Navigating Drug Development: The Critical Role of Performing...
International Day of Women and Girls in Science 2025: Inspiring...
Pharmaceutical Technology® spoke with Sabine Gölden, eLearning & Training Lead at MAIN5, about...
FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk
Ospomyv, a biosimilar to Prolia, is indicated for postmenopausal women and men at high risk of...
FDA Approves Bavarian Nordic’s Chikungunya Vaccine Vimkunya
Vimkunya is the first FDA-approved vaccine for chikungunya in patients over 12 years of age.
International Day of Women and Girls in Science: Fostering STEM...
Agnes Cwienczek, director of Product Management at ArisGlobal, talks with Pharmaceutical...
How Abpro Plans to Leverage the Public Markets
In this part of his Pharmaceutical Executive video interview, Ian Chan, CEO of Abpro talks about...
ArisGlobal Signs European Commission’s AI Pact
The pledge signifies ArisGlobal’s commitment to upholding high standards and best practices for...
Pharma Pulse 2/19/25: The Impact of Telehealth Reimbursement...
The latest news for pharma industry insiders.
FDA Approves Evrysdi Tablet from Roche for Spinal Muscular...
The approval makes Evrysdi the first and only tablet for treating spinal muscular atrophy.